Meet the Start-ups

Minmin (Mimi) Yen | CEO & Co-Founder | PhagePro

Dr. Minmin Yen (she/her) is passionate about using innovative solutions to reduce global health inequities. As the CEO and co-founder of the global health biotech startup PhagePro, Dr. Yen is dedicated to reducing antimicrobial resistance in resource-limited settings, with a focus on cholera. She strives to center the voices of the most marginalized in both biotech and global health communities.

For her work, Dr. Yen has been awarded multiple honors and fellowships including MIT Technology Review’s 35 Innovators Under 35, Boston Business Journal’s Women Who Mean Business award, and the Henri Termeer Legacy Program. Currently, she serves as a 2023 Millennium Leadership Fellow at the Atlantic Council and as a REVIVE Antimicrobial Resistance Expert for GARDP.

PhagePro

PhagePro is a Boston-based, mission-driven preclinical biotech startup committed to solving the antibiotic resistance crisis in emerging markets. Phages are viruses that target and kill bacteria, and its potential in treating diseases, most notably neglected diseases, earned phages a place on the World Economic Forum’s Top 10 Emerging Technologies. Using a phages-for-all approach, we apply our model of microbiology, global health, and public policy to develop equitable relationships with critical partners and demonstrate the potential of phage in outbreak settings.

PhagePro has raised over $4 million in grants and established four partnerships domestically and abroad. Led by CEO and co-founder Dr Minmin Yen, Ph.D., MPH, our team is committed to developing innovative phage-based treatments and building an equitable ecosystem that brings them to communities that need it the most.